Riata Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Riata Life Sciences Private Limited

Riata Life Sciences Private Limited, a amalgamated private limited company, was established on 03 January 2013 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U15100MH2013PTC402612. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹37.75 Cr and a paid-up capital of ₹36.85 Cr.

Formerly known as Riata Organics Private Limited. It upholds a compliant status. Employing 24 professional, Its leadership includes Manish Kumar Mittal (Director), Krishnamohan Puvvada (Director), Sanjay Ajabrao Soor (Director). Past directors included Anselm Julius Desouza, Biren Patel, Ashit Harshad Vora. It holds ₹5.00 M open charges and ₹11.00 Cr settled loans. Its latest AGM occurred on 12 December 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No 1503, 15Th Floor, Universal Majestic, Pl Lokhande Marg, Ghatkopar Mankhurd Link Road, Govandi, Mumbai, Maharashtra, 400043.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15100MH2013PTC402612

  • Registration Number

    402612

  • Incorporation Date

    03 January 2013

  • Authorized Capital

    ₹37.75 Cr

  • Paid-Up Capital

    ₹36.85 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 37.75 Cr
  • Paid Up Capital ₹ 36.85 Cr
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.00 M
  • Satisfied Charges ₹ 11.00 Cr
  • Revenue Growth **** 21.46%
  • Profit Growth **** 20.75%
  • Ebitda **** 407.60%
  • Net Worth -25.80%
  • Total Assets **** 7.04%
Company report

Riata Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Riata Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Riata Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Manish Kumar Mittal Director 09 Dec 2021 Current
Krishnamohan Puvvada Director 09 Dec 2021 Current
Sanjay Ajabrao Soor Director 09 Dec 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2013 Past
Pramod Abcsdd Director 03 Jan 2023 Past
Pramod Abcsdd Additional Director 30 Dec 2013 Past
Pramod Abcsdd Additional Director 30 Dec 2013 Past
Pramod Abcsdd Additional Director 30 Dec 2013 Past
Pramod Abcsdd Director 09 Dec 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Riata Life Sciences.

Riata Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.46% increase. The company also saw a substantial improvement in profitability, with a 20.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.8%.

Riata Life Sciences revenue growth over time
Riata Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 21.46%
*******
*******
*******
*******
Revenue from Operations
*******
 21.48%
*******
*******
*******
*******
Total Assets
*******
 7.04%
*******
*******
*******
*******
Profit or Loss
*******
 20.75%
*******
*******
*******
*******
Net Worth
*******
 -25.80%
*******
*******
*******
*******
EBITDA
*******
 407.60%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Riata Life Sciences?

In 2023, Riata Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,000,000.00

Satisfied Charges

₹110,000,000.00

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 11.00 Cr
Latest Charge Details
Date Lender Amount Status
20 Jun 2013 Bank Of Baroda ₹5.50 Cr Satisfied
10 Apr 2013 Bank Of Baroda ₹5.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Riata Life Sciences?

Riata Life Sciences has a workforce of 24 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Riata Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riata Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Riata Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Riata Life Sciences Private Limited last Annual general meeting of members was held on 12 Dec 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Riata Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    Manish Kumar Mittal was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Krishnamohan Puvvada was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 4 years 3 months . was completed.

  • Director Appointment

    The activity Sanjay Ajabrao Soor was appointed as a Director was appointed as a Director on 09 Dec 2021 & has been associated with this company since 4 years 3 months . was completed.

  • Charges

    Progress on A charge registered on 20 Jun 2013 via Charge ID 10482968 with Bank Of Baroda was fully satisfied on 15 Jan 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Riata Life Sciences Private Limited?

The CIN of Riata Life Sciences Private Limited is U15100MH2013PTC402612.

Where is Riata Life Sciences Private Limited headquartered?

Riata Life Sciences Private Limited is headquartered at Unit No 1503, 15Th Floor, Universal Majestic, Pl Lokhande Marg, Ghatkopar Mankhurd Link Road, Govandi, Mumbai, Maharashtra, 400043.

When was Riata Life Sciences Private Limited incorporated?

Riata Life Sciences Private Limited was incorporated on 03 January 2013.

Who are the current directors of Riata Life Sciences Private Limited?

The current directors of Riata Life Sciences Private Limited are

What is the primary industry of Riata Life Sciences Private Limited?

The primary industry of Riata Life Sciences Private Limited is Manufacturing.

Is Riata Life Sciences Private Limited a listed company?

Riata Life Sciences Private Limited is unlisted.

What is the capital structure of Riata Life Sciences Private Limited?

The authorized capital of Riata Life Sciences Private Limited is ₹37.75 Cr, and the paid-up capital is ₹36.85 Cr.

What is the compliance status of Riata Life Sciences Private Limited?

The compliance status of Riata Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available